Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
252.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.60 (0.238%)
Market Cap: £635.01m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Board changes

20 May 2021 07:01

RNS Number : 2050Z
Genuit Group PLC
20 May 2021
 

20 May 2021

Genuit Group plc

Board changes

Genuit Group plc ("Genuit", the "Company" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, today announces the following Board changes.

Chief Executive Officer to step down

Martin Payne has informed the Board of his intention to step down as Chief Executive Officer and from the Board. Martin will leave the Group during the first half of 2022, to support an orderly transition, after leading the business for five years. The Board is commencing a process to appoint a successor and the Company will provide an update as and when appropriate.

Ron Marsh, Chairman, commented: "On behalf of the Board I'd like to thank Martin for the significant contribution he has made to the Group over the last five years, particularly more recently in steering the Group successfully through the COVID-19 crisis. Martin has implemented a strategy to develop the Group into the broader water and climate management solutions markets, including six acquisitions, the most recent of which was the £210m acquisition of Adey. He leaves the Group in a strong position in growing markets with sustainability at its core. Following a recent successful re-branding to Genuit Group plc, the Group continues to capitalise on the opportunities ahead. We wish Martin well for the future."

Martin Payne, Chief Executive Officer, commented: "I am very proud to have been part of the team over the last five years and am pleased to be leaving Genuit Group in such a strong position. In our separate trading update today, we have seen a robust start to the year, with our positive performance testament to the tireless and successful work of our experienced team. I wish everyone at Genuit every success for the future and I look forward to working with the Board to ensure a smooth transition to my successor."

Appointment of Chief Operating Officer

The Board also announces the appointment of Matt Pullen as Chief Operating Officer (COO) with effect from 1 November 2021.

Matt will join Genuit Group's Board from British Gypsum, a part of the Saint-Gobain Group, based in the UK, where he served as Managing Director since 2018. Prior to that, he worked for AkzoNobel for 8 years undertaking various commercial and leadership roles of increasing seniority in the UK, Ireland and Northern Europe. His last role was Managing Director, UK & Ireland. Prior to that Matt held various operational roles within the FMCG sector.

Matt succeeds Glen Sabin, who as previously announced, is retiring. Glen assumed the role of Chief Operating Officer and was appointed to the Board on 2 October 2017 and will step down from the Board on 1 November 2021, leaving the Company after a short handover period with Matt.

Ron Marsh, Chairman, commented: "Matt is a highly experienced senior executive with a strong track record and is an extremely valuable addition to the team as we pursue our growth strategy".

Matt Pullen, commented, "I am delighted to have been appointed COO of Genuit Group. The Group has a significant presence in a number of high growth end-markets, with leading positions across the UK. I look forward to working alongside the Board and Executive Team to deliver continued performance across the Group."

There is no information concerning Mr Pullen which requires notification under LR9.6.13R of the Financial Conduct Authority's Listing Rules.

Enquiries:

Genuit Group

Martin Payne, Chief Executive Officer

Paul James, Chief Financial Officer

+44 (0) 1709 772 204

Brunswick

Nina Coad

Sophia Lazarus

+44 (0) 20 7404 5959

 

Notes to Editors:

Genuit Group plc ("Genuit" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, is the largest manufacturer in the UK, and among the ten largest manufacturers in Europe, of piping systems for the residential, commercial, civils and infrastructure sectors by revenue. It is also a leading designer and manufacturer of energy efficient ventilation systems in the UK.

 

The Group operates from 28 facilities in total, and manufactures the UK's widest range of solutions for heating, plumbing, drainage and ventilation. The Group primarily targets the UK and European building and construction markets with a presence in Italy, the Netherlands, Ireland and the Middle East and sales to specific niches in the rest of the world.

Genuit Group plc changed its corporate name from Polypipe Group plc on 6 April 2021. The Group was established in 1980 and has been listed on the London Stock Exchange since 2014.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAALMFTMTABBAB
Date   Source Headline
10th Jun 20244:32 pmRNSHolding(s) in Company
28th May 20242:14 pmRNSResult of AGM
28th May 20247:00 amRNSTrading Update
2nd May 20244:57 pmRNSBlock listing Interim Review
24th Apr 202410:39 amRNSNotice of AGM
10th Apr 20244:24 pmRNSDirector/PDMR Shareholding
10th Apr 20244:17 pmRNSDirector/PDMR Shareholding
9th Apr 20244:28 pmRNSDirector Declaration
2nd Apr 20243:56 pmRNSDirector/PDMR Shareholding
20th Mar 20243:27 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFinal Results
1st Mar 20248:30 amRNSDirector Declaration
19th Feb 20249:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20243:49 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSStrategy Progress Update Notification
15th Nov 20237:00 amRNSTrading Update
9th Nov 202310:08 amRNSDirector Declaration
2nd Nov 202311:59 amRNSDirector/PDMR Shareholding
1st Nov 20234:00 pmRNSBlock listing Interim Review
1st Nov 20237:00 amRNSDirectorate Change
25th Oct 20234:04 pmRNSDirector/PDMR Shareholding
17th Oct 20234:05 pmRNSDirector/PDMR Shareholding
11th Oct 20233:25 pmRNSDirector/PDMR Shareholding
6th Oct 20233:59 pmRNSDirector/PDMR Shareholding
11th Sep 202312:56 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Chief Financial Officer appointment
23rd Aug 20231:34 pmRNSDirector/PDMR Shareholding
18th Aug 202312:14 pmRNSDirector/PDMR Shareholding
16th Aug 202311:42 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSHalf-year Report
27th Jun 202312:01 pmRNSDirector/PDMR Shareholding
12th Jun 20234:11 pmRNSDirectorate Change
6th Jun 20237:00 amRNSDirectorate Change
18th May 202311:40 amRNSResult of AGM
18th May 20237:00 amRNSTrading Update
2nd May 20239:38 amRNSBlock listing Interim Review
25th Apr 20234:19 pmRNSDirector/PDMR Shareholding
25th Apr 20234:16 pmRNSDirector/PDMR Shareholding
18th Apr 202310:49 amRNSNotice of AGM
13th Apr 20233:57 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
31st Mar 20234:27 pmRNSDirector/PDMR Shareholding
17th Mar 202311:28 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
8th Mar 20234:26 pmRNSBoard updates
28th Feb 20235:55 pmRNSHolding(s) in Company
27th Feb 20239:36 amRNSDirectorate Change
31st Jan 202310:22 amRNSDirector Declaration
26th Jan 20236:27 pmRNSHolding(s) in Company
28th Nov 20224:05 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.